Goodwin is a heavyweight international law firm that brings a broad range of skills to bear on work for world-leading companies in the tech and life sciences markets, with intellectual property high on the list of its core strengths. The team in Cambridge is led by IP commercialisation expert Malcolm Bates and Tim Worden, who assists life sciences companies with licensing and partnering deals, R&D agreements, clinical trials agreements, distribution agreements, and a broad array of regulatory matters. Georgia Powell is a key adviser on non-contentious intellectual property and commercial matters in the life sciences, technology and healthcare sectors. Worden recently assisted Synaffix with a $368m licensing deal for access to its clinical stage, site-specific ADC technology platform for the development of selective cancer therapies.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
- 'The team have spent a significant amount of time to deeply understand our technology and market. This enables them to get to the crux of what matters in a commercial discussion with customers.'
- 'Highly responsive and creative in dealing with challenging negotiations. Worked efficiently to progress to closure keeping entire team in the loop and made constructive suggestions to resolve open business and legal issues.'
- 'The leadership of Tim Worden who spearheaded our legal team at Goodwin was of particular merit. Tim's keen understanding of transactional issues and regional laws (UK) expedited the entire process.'
- 'The people - they invest in relationships as well as delivering excellent service.'
- 'Depth and breadth of knowledge and a personal touch.'
Key clients
- Synaffix
- ViceBio
- MiNA Therapeutics
- Ateda Therapeutics
- SpyBiotech
- Broken String
- BioGeneration
- PharmEnable
- Aavantgarde Bio
- Closed Loop Medicine
- Ellipses Pharma
- Engnitix
Work highlights
Advised Synaffix on a license agreement with Elevation Oncology, Inc. with Synaffix to receive up to $368 million in upfront and clinical, regulatory, and commercial milestone payments, plus tiered royalties on net sales.
Advised Vicebio on its $100 million Series B financing led by TCGX with investment from Goldman Sachs Alternatives, Avoro Ventures, venBio, and participation from UniQuest and founding investor Medicxi
Advised MiNA Therapeutics on enteringinto a research collaboration and option licensing agreement with Nippon Shinyaku.
Lawyers
Hall of Fame
The lawyers at the very top of the profession, widely known and respected by peers and clients for their longstanding involvement in market-leading work.
Leading associates
Leading associates with regular involvement in their team's key work, and recognition from peers or clients as being ones to watch.
Practice head
Malcolm Bates; Tim Worden
Other key lawyers
Georgia Powell